Dr Robert Ervin Smith Iii, MD | |
2100 Stantonsburg Rd, Greenville, NC 27834-2818 | |
(252) 847-4100 | |
Not Available |
Full Name | Dr Robert Ervin Smith Iii |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 2100 Stantonsburg Rd, Greenville, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215556600 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Ervin Smith Iii, MD 2100 Stantonsburg Rd, Greenville, NC 27834-2818 Ph: (252) 744-2663 | Dr Robert Ervin Smith Iii, MD 2100 Stantonsburg Rd, Greenville, NC 27834-2818 Ph: (252) 847-4100 |
News Archive
New research from North Carolina State University and the University of Minnesota shows that the majority of consumers will accept the presence of nanotechnology or genetic modification (GM) technology in foods - but only if the technology enhances the nutrition or improves the safety of the food.
Baltimore, MD-The innovative, educational, outreach program BioEYES has now been adopted by the University of Melbourne and the Australian Regenerative Medicine Institute. The down-under partnership program debuts this August. BioEYES is designed to foster an interest in and a love for science in elementary, middle, and high school students. Over the course of one week, students watch the transparent zebrafish, Danio rerio, grow from a single-celled zygote to a larval fish complete with a beating heart.
News outlets offer tips and answers for consumers who are trying to understand the health insurance they now have as a result of the health law.
The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including Professors Vineet Bafna and Dr.Paul Mischel of the University of California San Diego and Professor Roel Verhaak of Jackson Laboratories.
› Verified 4 days ago